Advancements in Intelligent Aesthetics: Alma at IMCAS World Congress 2026

Alma, a prominent brand under Sisram Medical, made waves at the IMCAS World Congress held in Paris from January 29-31, 2026, with a forward-looking vision in the realm of Intelligent Aesthetics. This event, known for its significant influence in the medical aesthetics industry, served as a platform for Alma to unveil its latest innovations and a commitment to providing practitioners with cutting-edge, evidence-based solutions aimed at enhancing patient outcomes.

During the Congress, Sisram Medical presented new clinical data underscoring its leadership position in the field of energy-based aesthetic solutions. Central to these presentations was the introduction of multi-technology laser platforms, which are essential for advanced rejuvenation treatments and complex tattoo removals. These advancements reflect Alma’s ongoing dedication to integrating scientific rigor with technological innovation in aesthetic practices.

One key highlight was the presentation of findings related to the Alma Hybrid platform, used for effectively managing keloid scars in conjunction with surgical interventions. This research emphasizes the multifaceted capabilities of Alma's products and their role in addressing a variety of skin concerns. In addition, the company showcased its award-winning treatment, Harmony Bio-Boost, which stimulates collagen production, further reinforcing Alma’s innovative approach to rejuvenation.

Moreover, Alma IQ, an advanced skin analysis platform, illustrated how technology can enhance personalized patient assessments. By enabling practitioners to create precise treatment plans right from the first patient interaction, Alma IQ empowers medical professionals to deliver tailored care that meets individual needs.

The significance of the IMCAS World Congress extends beyond just technological presentations; it serves as a collaborative environment where leading figures in aesthetics gather to shape the future of the industry. Mr. Eyal Ben David, CEO of Sisram and Alma, stated, “IMCAS stands among the most influential scientific platforms shaping the future of medical aesthetics. Our expanded presence this year underscores Alma's commitment to redefining aesthetic care through rigorous clinical evidence and disruptive technological innovation.”

The event also hosted the IMCAS World Congress Economic Forum, where Mr. Lior Dayan, Chairman of Sisram, participated in discussions with global industry leaders about the transformative impact of intelligent technologies on medical aesthetics. The insights shared during this forum highlighted the essential role that clinical data and innovative solutions play in shaping patient-centered care.

The future of Intelligent Aesthetics, as presented by Alma at IMCAS 2026, is not merely about technological advancement; it is about a paradigm shift towards more personalized and effective treatments. By delivering evidence-driven solutions, Alma is committed to elevating the standard of care within the aesthetic industry, fostering long-term relationships between practitioners and their patients.

As Sisram Medical continues to push the boundaries of aesthetic solutions, its influence in the global market remains strong, serving clients across over 110 countries. This expansive reach ensures that the innovations discussed at IMCAS will ultimately benefit millions of patients seeking safe and effective aesthetic treatments.

For more information about Alma and Sisram Medical’s products, visitors can check their website at Sisram Medical.